Endothelial-specific delivery of PGC1α using nanoparticles was also reported to prevent hypoxia-induced pulmonary hypertension through inhibition of EndMT-induced vascular remodeling65, thus mirroring what we observed in the cancer cachexia setting. The gene discussed is PPARGC1A; the disease is pulmonary arterial hypertension.